EDTUTC-4 New YorkLog in Sign up

TAK
Takeda Pharmaceutical Company Limited
stockNYSEADR

At CloseOct 2, 2026 3:59:58 PM EDT

17.86USD0.000%(0.00)2,132,769

TAK News

Day breaks

11:43 AM EDTCorus International Receives $6.4 Million Grant From Takeda to Reduce Climate-Related Health Risks in Nepal ·

Business Wire

02:03 AM EDTTakeda's Zasocitinib Shows Superior Skin Clearance In Phase 3 Psoriasis Trial ·

RTTNews

01:04 AM EDTZasocitinib Delivered Superior Efficacy Versus Deucravacitinib in New Phase 3 Head-to-Head Results, Reinforcing Potential to Deliver Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill ·

Financial Post

09:30 AM EDTTakeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 2026 ·

Financial Post

01:03 AM EDTTakeda Employees Select Four New Global Corporate Social Responsibility Collaborations to Advance Climate-Resilient Health Systems ·

Financial Post

01:00 AM EDTTakeda Employees Select Four New Global Corporate Social Responsibility Collaborations to Advance Climate-Resilient Health Systems ·

Business Wire

01:08 PM EDTTakeda Pharmaceutical (TAK) Gets Priority Review. Can Zasocitinib Win in Psoriasis? ·

Insider Monkey

05:00 AM EDTHummingbird Bioscience Appoints Dr. James Garner as President ·

GlobeNewswire Inc.

06:43 AM EDTAmgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026? ·

The Motley Fool

05:28 AM EDTBest Income Stocks to Buy for September 14th ·

Zacks Investment Research

08:30 PM EDTIntravenous Immunoglobulin Market Size Worth USD 30.83 Billion by 2035, Growing at 7.49% CAGR – SNS Insider ·

GlobeNewswire Inc.

08:30 PM EDTMonoclonal Antibodies Market to Grow at 11.01% CAGR, Reaching USD 791.28 Billion by 2035 – SNS Insider ·

GlobeNewswire Inc.

06:52 AM EDTDrug Repurposing Market to Reach USD 50.91 Billion by 2035, Expanding at 3.93% CAGR | SNS Insider ·

GlobeNewswire Inc.

08:30 AM EDTIf You Invested $1000 in Halozyme Therapeutics a Decade Ago, This is How Much It'd Be Worth Now ·

Zacks Investment Research

04:04 AM EDTFabry Disease Treatment Market 2026-2031 - Growth Driven by Increasing Adoption of Enzyme Replacement Therapy ·

GlobeNewswire Inc.